Diagnosed with neuroblastoma at just 16, Malena from Buenos Aires faced a long and difficult journey.
After multiple rounds of chemotherapy, surgery, and immunotherapy, her options were running out. Access to Radioligand Therapy seemed impossible until the Oncidium foundation, through its RLT-Connect program, stepped in to cover her first treatments.
Today, Malena can finally look ahead with renewed hope, dreaming of travel, music, and a life beyond cancer.
Her story is a powerful reminder of why patient access remains at the heart of our mission.
